Gland Pharma Ltd

GLAND

Company Profile

  • Business description

    Gland Pharma Ltd is engaged in the development, manufacturing, and marketing of complex injectables. The company's key molecules include Heparin Sodium Injection, Enoxaparin Sodium Injection, Rocuronium Bromide Injection, and Daptomycin Injection, among others. The group is also involved in a vast range of therapeutic categories, including Anti-Infectives, Anesthetics, Anti-Coagulants and their Antidotes, Anti-Malarials, Cardiology, and more, to Hormones and related Drugs, Fertility Supplements, and GnRH Agonists and Antagonists. Geographically, it derives a majority of revenue from the USA, and the rest from Europe, India, Canada, Australia, and other regions.

  • Contact

    TSIIC, Phase - IV
    Plot No. 11 and 84
    Pashamylaram (V), Patancheru M
    Sangareddy District
    HyderabadTG502307
    IND

    T: +91 8455699999

    https://www.glandpharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2027

    Employees

    4,351

Stocks News & Analysis

stocks

Hostile takeover on the cards for this ASX income opportunity

IFM lobs reasonable takeover offer.
stocks

Get ready for major US tech earnings starting tomorrow morning

Microsoft, Amazon, Alphabet, and Meta will all release quarterly earnings. Here’s what analysts are looking for.
stocks

Corning’s AI fiber boom is real, but its stock price may be getting out of hand

Corning’s optical fiber business is thriving, and the Meta deal derisks its supply buildout, but success isn’t guaranteed.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,908.108.400.09%
CAC 408,104.0937.83-0.46%
DAX 4024,018.2665.27-0.27%
Dow JONES (US)49,141.9325.86-0.05%
FTSE 10010,332.7911.700.11%
HKSE25,679.78245.87-0.95%
NASDAQ24,663.80223.30-0.90%
Nikkei 22559,917.46619.90-1.02%
NZX 50 Index12,731.9832.42-0.25%
S&P 5007,138.8035.11-0.49%
S&P/ASX 2008,682.805.200.06%
SSE Composite Index4,078.647.71-0.19%

Market Movers